Sporos Bioventures

Sporos Bioventures is a biotechnology company focused on oncology, fibrosis, inflammation, as well as autoimmune and infectious disease therapies. Sporos is transforming knowledge into new hope for patients with cancer and immune disorders. Sporos identifies novel disease mechanisms and strategically deploys talent, funding, and operational resources to advance the development of breakthrough drugs. Its current pipeline spans four entities, including multiple clinical-stage drug candidates being investigated for various indications in the treatment of cancer and immune-related diseases.